Raynaud's Phenomenon Clinical Trial
Official title:
Phase IIa Study of the Efficacy of ORM-12471 for Prevention of Cold-induced Vasospasm: a Randomised, Double-blind, Placebo-controlled, Single Centre Crossover Study in Patients With Raynaud's Phenomenon Secondary to Systemic Sclerosis
Raynaud's phenomenon (RP) is a disorder of the digital blood vessels resulting in episodic impairment of blood flow. During an attack of RP which commonly affects the hands and feet these arteries contract briefly which limits the blood flow (this is called a vasospasm) and deprived of blood the skin turns white then blue. The aim of this study is to prove the concept that ORM-12741 can prevent these blood vessel spasms.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00946738 -
The Effect of Physical Therapy on Raynaud`s Phenomenon Secondary to Systemic Sclerosis
|
N/A | |
Completed |
NCT02050360 -
"As Required" Oral Sildenafil in Raynaud's Phenomenon
|
Phase 2/Phase 3 | |
Completed |
NCT01117298 -
A Randomized Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma
|
Phase 3 | |
Completed |
NCT02583789 -
Assess Efficacy of of Oral Treprostinil in Patients With Symptomatic Primary or Secondary Raynaud's Phenomenon
|
Early Phase 1 | |
Completed |
NCT03058887 -
The Effects of Exercise in Patients With Systemic Sclerosis
|
N/A | |
Completed |
NCT00700518 -
Dose Response to Topical Glyceryl Trinitrate in Patients With Raynaud's Phenomenon
|
Phase 1 | |
Completed |
NCT02506062 -
A Trial of Ischemic Preconditioning in Raynaud's Phenomenon (RP)
|
N/A | |
Recruiting |
NCT01378845 -
Prognostic Influence of Light Rheography Measurement of Patients With Secondary Raynaud Syndrome With Ulcers on Hands
|
N/A | |
Completed |
NCT00841594 -
MQX-503 Applied to the Hand Versus Nitroglycerin Ointment Applied to the Chest: A Pharmacokinetic Comparison
|
Phase 1 |